FDA NDC Directory · JSON-LD · Markdown

Neostigmine methylsulfate

NDC 71839-105 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerBE Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA212512
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNEOSTIGMINE METHYLSULFATE (.5 mg/mL)
Marketing started20190513
Package count2

External sources

Source: openFDA. Public-domain (CC0).